Changlin Lu

发表

Parathyroid hormone, cardiovascular and all-cause mortality: A meta-analysis.

Bo Yang, Changlin Lu, Qing Wu, 2016, Clinica chimica acta; international journal of clinical chemistry.

Chronic kidney disease, all-cause mortality and cardiovascular mortality among Chinese patients with established cardiovascular disease.

Jingang Yang, Yuejin Yang, D. Hu, 2010, Journal of atherosclerosis and thrombosis.

Circulating microRNAs as potential biomarkers for coronary plaque rupture

F. Zhang, Sufang Li, Yuxia Cui, 2017, Oncotarget.

Different therapeutic proportion of patients undergone coronary angiography in the era of development in MSCT

Pengchuan Zhang, D. Hu, C. Hu, 2008 .

PPAR-α Agonist Fenofibrate Upregulates Tetrahydrobiopterin Level through Increasing the Expression of Guanosine 5′-Triphosphate Cyclohydrolase-I in Human Umbilical Vein Endothelial Cells

Jinbo Liu, Xian Wang, Hai-ning Wang, 2011, PPAR research.

Hepatocellular carcinoma: stiffness value and ratio to discriminate malignant from benign focal liver lesions.

Q. Lu, Yan Luo, T. Wen, 2015, Radiology.

Effects of Nano-Protein Complexes on Apoptosis of Myocardial Infarction Cells Based on Complex Curve Analysis.

Bo Yang, Changlin Lu, Hua Zhao, 2021, Journal of nanoscience and nanotechnology.

The efficacy of LCZ696 in chronic heart failure

Jiayao Wang, Changlin Lu, Yao Ma, 2019 .

The Association between Atherosclerotic Renal Artery Stenosis and Acute Kidney Injury in Patients Undergoing Cardiac Surgery

Jingang Yang, Yuejin Yang, D. Hu, 2013, PloS one.

Stiffness Value and Serum Biomarkers in Liver Fibrosis Staging: Study in Large Surgical Specimens in Patients with Chronic Hepatitis B.

Q. Lu, Yan Luo, T. Wen, 2016, Radiology.